Logo image of CTRA

COTERRA ENERGY INC (CTRA) Stock Fundamental Analysis

NYSE:CTRA - New York Stock Exchange, Inc. - US1270971039 - Common Stock - Currency: USD

25.22  +0.19 (+0.76%)

After market: 25.18 -0.04 (-0.16%)

Fundamental Rating

6

Overall CTRA gets a fundamental rating of 6 out of 10. We evaluated CTRA against 211 industry peers in the Oil, Gas & Consumable Fuels industry. CTRA has only an average score on both its financial health and profitability. CTRA is growing strongly while it also seems undervalued. This is an interesting combination


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CTRA had positive earnings in the past year.
In the past year CTRA had a positive cash flow from operations.
In the past 5 years CTRA has always been profitable.
CTRA had a positive operating cash flow in each of the past 5 years.
CTRA Yearly Net Income VS EBIT VS OCF VS FCFCTRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

1.2 Ratios

CTRA has a better Return On Assets (5.36%) than 61.61% of its industry peers.
CTRA has a Return On Equity (9.02%) which is in line with its industry peers.
The Return On Invested Capital of CTRA (5.89%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for CTRA is significantly below the industry average of 23.70%.
The 3 year average ROIC (12.27%) for CTRA is well above the current ROIC(5.89%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 5.36%
ROE 9.02%
ROIC 5.89%
ROA(3y)11.08%
ROA(5y)8.7%
ROE(3y)17.66%
ROE(5y)14.37%
ROIC(3y)12.27%
ROIC(5y)9.93%
CTRA Yearly ROA, ROE, ROICCTRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

CTRA's Profit Margin of 21.66% is fine compared to the rest of the industry. CTRA outperforms 72.51% of its industry peers.
CTRA's Profit Margin has declined in the last couple of years.
CTRA has a Operating Margin of 27.78%. This is in the better half of the industry: CTRA outperforms 65.88% of its industry peers.
In the last couple of years the Operating Margin of CTRA has declined.
With an excellent Gross Margin value of 81.23%, CTRA belongs to the best of the industry, outperforming 91.94% of the companies in the same industry.
In the last couple of years the Gross Margin of CTRA has grown nicely.
Industry RankSector Rank
OM 27.78%
PM (TTM) 21.66%
GM 81.23%
OM growth 3Y-19.39%
OM growth 5Y-9.76%
PM growth 3Y-15.14%
PM growth 5Y-9.04%
GM growth 3Y1.7%
GM growth 5Y3.22%
CTRA Yearly Profit, Operating, Gross MarginsCTRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

4

2. Health

2.1 Basic Checks

CTRA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CTRA has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CTRA has more shares outstanding
The debt/assets ratio for CTRA is higher compared to a year ago.
CTRA Yearly Shares OutstandingCTRA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
CTRA Yearly Total Debt VS Total AssetsCTRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

CTRA has an Altman-Z score of 2.02. This is not the best score and indicates that CTRA is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.02, CTRA is doing good in the industry, outperforming 66.82% of the companies in the same industry.
CTRA has a debt to FCF ratio of 3.40. This is a good value and a sign of high solvency as CTRA would need 3.40 years to pay back of all of its debts.
The Debt to FCF ratio of CTRA (3.40) is better than 76.78% of its industry peers.
A Debt/Equity ratio of 0.30 indicates that CTRA is not too dependend on debt financing.
CTRA's Debt to Equity ratio of 0.30 is fine compared to the rest of the industry. CTRA outperforms 62.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 3.4
Altman-Z 2.02
ROIC/WACC0.66
WACC8.87%
CTRA Yearly LT Debt VS Equity VS FCFCTRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

CTRA has a Current Ratio of 0.90. This is a bad value and indicates that CTRA is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.90, CTRA is doing worse than 62.56% of the companies in the same industry.
CTRA has a Quick Ratio of 0.90. This is a bad value and indicates that CTRA is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CTRA (0.86) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.9
Quick Ratio 0.86
CTRA Yearly Current Assets VS Current LiabilitesCTRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

7

3. Growth

3.1 Past

CTRA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.13%.
Measured over the past 5 years, CTRA shows a small growth in Earnings Per Share. The EPS has been growing by 0.12% on average per year.
Looking at the last year, CTRA shows a small growth in Revenue. The Revenue has grown by 6.45% in the last year.
Measured over the past years, CTRA shows a very strong growth in Revenue. The Revenue has been growing by 21.44% on average per year.
EPS 1Y (TTM)3.13%
EPS 3Y-5.3%
EPS 5Y0.12%
EPS Q2Q%56.86%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y16.53%
Revenue growth 5Y21.44%
Sales Q2Q%32.87%

3.2 Future

CTRA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.70% yearly.
CTRA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.91% yearly.
EPS Next Y64.74%
EPS Next 2Y36.7%
EPS Next 3Y26.45%
EPS Next 5Y25.7%
Revenue Next Year38.79%
Revenue Next 2Y22.29%
Revenue Next 3Y15.91%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CTRA Yearly Revenue VS EstimatesCTRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
CTRA Yearly EPS VS EstimatesCTRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 1 2 3 4 5

8

4. Valuation

4.1 Price/Earnings Ratio

CTRA is valuated correctly with a Price/Earnings ratio of 12.74.
Based on the Price/Earnings ratio, CTRA is valued a bit cheaper than 60.66% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.45. CTRA is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 7.99, the valuation of CTRA can be described as very cheap.
Based on the Price/Forward Earnings ratio, CTRA is valued a bit cheaper than the industry average as 77.73% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of CTRA to the average of the S&P500 Index (21.90), we can say CTRA is valued rather cheaply.
Industry RankSector Rank
PE 12.74
Fwd PE 7.99
CTRA Price Earnings VS Forward Price EarningsCTRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

64.45% of the companies in the same industry are more expensive than CTRA, based on the Enterprise Value to EBITDA ratio.
63.03% of the companies in the same industry are more expensive than CTRA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.27
EV/EBITDA 6.57
CTRA Per share dataCTRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CTRA has a very decent profitability rating, which may justify a higher PE ratio.
CTRA's earnings are expected to grow with 26.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.2
PEG (5Y)107.25
EPS Next 2Y36.7%
EPS Next 3Y26.45%

5

5. Dividend

5.1 Amount

CTRA has a Yearly Dividend Yield of 3.31%. Purely for dividend investing, there may be better candidates out there.
CTRA's Dividend Yield is comparable with the industry average which is at 6.51.
CTRA's Dividend Yield is a higher than the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 3.31%

5.2 History

On average, the dividend of CTRA grows each year by 18.85%, which is quite nice.
CTRA has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)18.85%
Div Incr Years0
Div Non Decr Years0
CTRA Yearly Dividends per shareCTRA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

50.23% of the earnings are spent on dividend by CTRA. This is a bit on the high side, but may be sustainable.
The dividend of CTRA is growing, but earnings are growing more, so the dividend growth is sustainable.
DP50.23%
EPS Next 2Y36.7%
EPS Next 3Y26.45%
CTRA Yearly Income VS Free CF VS DividendCTRA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B
CTRA Dividend Payout.CTRA Dividend Payout, showing the Payout Ratio.CTRA Dividend Payout.PayoutRetained Earnings

COTERRA ENERGY INC

NYSE:CTRA (7/3/2025, 7:14:30 PM)

After market: 25.18 -0.04 (-0.16%)

25.22

+0.19 (+0.76%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners91.79%
Inst Owner Change0%
Ins Owners0.87%
Ins Owner Change1.98%
Market Cap19.25B
Analysts82.58
Price Target33.64 (33.39%)
Short Float %3.65%
Short Ratio3.63
Dividend
Industry RankSector Rank
Dividend Yield 3.31%
Yearly Dividend0.84
Dividend Growth(5Y)18.85%
DP50.23%
Div Incr Years0
Div Non Decr Years0
Ex-Date05-15 2025-05-15 (0.22)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.8%
Min EPS beat(2)-1.36%
Max EPS beat(2)10.97%
EPS beat(4)1
Avg EPS beat(4)-1.37%
Min EPS beat(4)-7.78%
Max EPS beat(4)10.97%
EPS beat(8)4
Avg EPS beat(8)3.94%
EPS beat(12)8
Avg EPS beat(12)5.42%
EPS beat(16)9
Avg EPS beat(16)1.31%
Revenue beat(2)1
Avg Revenue beat(2)-2.17%
Min Revenue beat(2)-5.32%
Max Revenue beat(2)0.98%
Revenue beat(4)2
Avg Revenue beat(4)-2.07%
Min Revenue beat(4)-6.2%
Max Revenue beat(4)2.26%
Revenue beat(8)4
Avg Revenue beat(8)-1.96%
Revenue beat(12)8
Avg Revenue beat(12)1.64%
Revenue beat(16)9
Avg Revenue beat(16)-1.78%
PT rev (1m)-1.16%
PT rev (3m)-4.48%
EPS NQ rev (1m)-0.48%
EPS NQ rev (3m)-20.13%
EPS NY rev (1m)-3.03%
EPS NY rev (3m)-14.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.62%
Revenue NY rev (1m)-0.35%
Revenue NY rev (3m)-4.35%
Valuation
Industry RankSector Rank
PE 12.74
Fwd PE 7.99
P/S 3.25
P/FCF 15.27
P/OCF 6.24
P/B 1.35
P/tB 1.35
EV/EBITDA 6.57
EPS(TTM)1.98
EY7.85%
EPS(NY)3.16
Fwd EY12.52%
FCF(TTM)1.65
FCFY6.55%
OCF(TTM)4.04
OCFY16.02%
SpS7.77
BVpS18.65
TBVpS18.65
PEG (NY)0.2
PEG (5Y)107.25
Profitability
Industry RankSector Rank
ROA 5.36%
ROE 9.02%
ROCE 7.37%
ROIC 5.89%
ROICexc 5.94%
ROICexgc 5.94%
OM 27.78%
PM (TTM) 21.66%
GM 81.23%
FCFM 21.27%
ROA(3y)11.08%
ROA(5y)8.7%
ROE(3y)17.66%
ROE(5y)14.37%
ROIC(3y)12.27%
ROIC(5y)9.93%
ROICexc(3y)12.9%
ROICexc(5y)10.44%
ROICexgc(3y)12.9%
ROICexgc(5y)10.44%
ROCE(3y)15.36%
ROCE(5y)12.44%
ROICexcg growth 3Y-7.45%
ROICexcg growth 5Y-19.44%
ROICexc growth 3Y-7.45%
ROICexc growth 5Y-19.44%
OM growth 3Y-19.39%
OM growth 5Y-9.76%
PM growth 3Y-15.14%
PM growth 5Y-9.04%
GM growth 3Y1.7%
GM growth 5Y3.22%
F-Score5
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 3.4
Debt/EBITDA 1.2
Cap/Depr 95.59%
Cap/Sales 30.73%
Interest Coverage 250
Cash Conversion 86.77%
Profit Quality 98.21%
Current Ratio 0.9
Quick Ratio 0.86
Altman-Z 2.02
F-Score5
WACC8.87%
ROIC/WACC0.66
Cap/Depr(3y)110.23%
Cap/Depr(5y)116.61%
Cap/Sales(3y)28.94%
Cap/Sales(5y)29.44%
Profit Quality(3y)93.33%
Profit Quality(5y)92.4%
High Growth Momentum
Growth
EPS 1Y (TTM)3.13%
EPS 3Y-5.3%
EPS 5Y0.12%
EPS Q2Q%56.86%
EPS Next Y64.74%
EPS Next 2Y36.7%
EPS Next 3Y26.45%
EPS Next 5Y25.7%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y16.53%
Revenue growth 5Y21.44%
Sales Q2Q%32.87%
Revenue Next Year38.79%
Revenue Next 2Y22.29%
Revenue Next 3Y15.91%
Revenue Next 5YN/A
EBIT growth 1Y-3.97%
EBIT growth 3Y-6.06%
EBIT growth 5Y9.59%
EBIT Next Year248.25%
EBIT Next 3Y57.09%
EBIT Next 5Y36.3%
FCF growth 1Y-65.96%
FCF growth 3Y2.93%
FCF growth 5Y9.27%
OCF growth 1Y-45.22%
OCF growth 3Y18.8%
OCF growth 5Y14.09%